Bristol-Myers Squibb buy fenjal
Start price
25.03.22
/
50%
€66.35
Target price
25.04.22
-
Performance (%)
6.07%
End price
26.04.22
€70.38
Summary
This prediction ended on 26.04.22 with a price of €70.38. With a performance of 6.07%, the BUY prediction by fenjal for Bristol-Myers Squibb closed with a slight gain. A total of €0.49 was paid as dividends for this prediction. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bristol-Myers Squibb | 18.551% | 18.551% | -16.589% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% |
According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons
Comments by fenjal for this prediction
In the thread Trading Bristol-Myers Squibb
Die von fenjal gewählte maximale Laufzeit wurde überschritten
Stopped prediction by fenjal for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.10
01.05.24
01.05.24
-
01.05.25
01.05.25
11.46%
26.07.24
26.07.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.54
18.04.19
18.04.19
€52.32
09.06.20
09.06.20
30.00%
09.06.20
09.06.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating